{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-076349","form_type":"8-K","ticker":null,"cik":"0001633070","company_name":"Axcella Health Inc.","filed_at":"2023-06-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.749393+00:00","generated_at":"2026-06-13T14:54:39.594321+00:00","sec_items":["3.01","5.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Axcella Health receives Nasdaq delisting notice for bid price non-compliance; CMO resigns","bullets":["Nasdaq notified Axcella of delisting for non-compliance with $1.00 bid price; delisting set for July 10, 2023 unless hearing requested.","Company plans to request hearing to stay delisting; stock remains listed pending outcome.","Previous 180-day grace period to regain $1.00 bid price ended June 28, 2023 without compliance.","Chief Medical Officer Margaret Koziel resigned effective June 23, 2023; will consult on restructuring."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-076349","json":"https://secwatch.observer/filing/0001104659-23-076349.json","markdown":"https://secwatch.observer/filing/0001104659-23-076349.md","text":"https://secwatch.observer/filing/0001104659-23-076349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923076349/0001104659-23-076349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923076349/tm2320233d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T14:54:39.594321+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e99fc1a22b4119a68f259d87135ec4883e0aaebe","claim":"Axcella Health Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"June 29, 2023, Axcella Health Inc., (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) as of June 28, 2023, the Company would be delisted at the opening of business on July 10, 2023 unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”) to address the deficiencies and present a plan to regain compliance. The Company plans to timely request a hearing before the","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923076349/0001104659-23-076349-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"bf0e25db05","claim":"Margaret Koziel resigned as Senior Vice President and Chief Medical Officer at Axcella Health Inc..","evidence_excerpt":"On June 23, 2023, Margaret Koziel, M.D., who has served as the Company’s Senior Vice President and Chief Medical Officer, notified the Company of her resignation from the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923076349/0001104659-23-076349-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Senior Vice President and Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}